Aflac Reports Q2 Earnings Amid Investment Losses

AFLAC Incorporated ( (AFL) ) has released its Q2 earnings. Here is a breakdown of the information AFLAC Incorporated presented to its investors.

Aflac Incorporated, a Fortune 500 company, is a leading provider of supplemental health insurance in the U.S. and cancer and medical insurance in Japan, known for its ethical business practices and commitment to corporate social responsibility. In its latest earnings report, Aflac announced second-quarter net earnings of $599 million, a significant decline from the previous year, primarily due to net investment losses. Despite the challenges, the company declared a third-quarter dividend, reflecting its ongoing commitment to returning capital to shareholders.

The company’s total revenues for the second quarter of 2025 were $4.2 billion, down from $5.1 billion in the same period of 2024, largely due to a $421 million net investment loss. Adjusted earnings also saw a decrease, with a 7.5% drop to $957 million. Aflac’s operations in Japan experienced a decline in net earned premiums and adjusted net investment income, while the U.S. segment showed a modest increase in net earned premiums and sales. The company also repurchased $829 million in shares during the quarter.

Aflac Japan reported a 23.2% increase in new annualized premium sales, driven by the success of its new cancer insurance product, Miraito. However, the segment faced challenges with a decrease in net earned premiums and adjusted net investment income. In the U.S., Aflac saw a 3.4% increase in net earned premiums, supported by strong sales of group life and disability products, despite a decrease in adjusted net investment income.

Looking ahead, Aflac’s management remains optimistic about the company’s strategy to focus on profitable growth in both the U.S. and Japan. The company aims to continue enhancing its product offerings and distribution strategies to meet the evolving needs of its customers. Aflac’s commitment to maintaining a strong financial position and delivering long-term value to shareholders remains a priority.